Detail

30.01.2015

Spin-off project dermaSight at Helmholtz Zentrum München receives funding

Quickly translating research findings into applications and thereby using them for social and commercial benefit is the aim of the Helmholtz Enterprise funding programme. Three new spin-offs from Helmholtz Centres - including the project dermaSight at Helmholtz Zentrum München - have recently been approved for funding. The entrepreneurs receive seed capital of up to €260,000. Half of this comes from the Helmholtz Association’s Initiative and Networking Fund, while the other half is contributed by the centre involved. Since 2005, Helmholtz has funded 89 spin-off projects proposed by researchers. In particular, Helmholtz Enterprise provides these new businesses with security during the critical start-up phase.

Spin-off project dermaSight at Helmholtz Zentrum München erhält receives funding

Logo Helmholtz Association

"Taking good ideas for innovative products or services and developing a workable business model from them is always a major challenge,” says Rolf Zettl, Managing Director of the Helmholtz Association. He points out that the start-up phase is particularly difficult, because the necessary funding and staffing are often not in place. “To enable the transfer from the laboratory to commercial application to succeed, we help scientists at our centres find their feet as entrepreneurs.” Helmholtz Enterprise funding is designed to bridge the gap that so often occurs in the first phase and to give founders the breathing space they need to further develop their business plans, Zettl explains. To boost the projects’ chances of success even more, Helmholtz also assists founders by providing advice from experienced experts.

dermaSight – innovative imaging technique for dermatological and endoscopic applications

Commercial development of a new imaging tool for dermatological and endoscopic investigations is the subject of the planned dermaSight spin-off from Helmholtz Zentrum München. Using a new ultra-broadband optoacoustic mesoscopy technique it is possible to produce high-resolution 3D images that measure molecular and physiological parameters in real time. The major benefit for future users lies in fast and reliable diagnosis – which means, for example, that skin cancer can be detected earlier. The technique can also be used for purposes such as detecting bowel cancer and supporting surgical procedures. The dermaSight technology is particularly useful when used in conjunction with multi-spectral optoacoustic tomography: this has been made possible through cooperation with a business that had already successfully spun off from the Helmholtz Centre.

Furthermore, spin-offs at German Aerospace Center (Deutsches Zentrums für Luft- und Raumfahrt: tacterion – tactile sensor systems for robotics and medical technology) and at German Research Centre for Geosciences (Helmholtz Zentrum Potsdam – Deutsches GeoForschungsZentrum: TRIDEC Cloud – web-based platform for reliable assessment of hazard potential) receive funding by Helmholtz Enterprise.


Further Information

Scientific contact for dermaSight at Helmholtz Zentrum München:
Prof. Vasilis Ntziachristos, Helmholtz Zentrum München - German Research Center for Environmental Health (GmbH), Institute of Biological and Medical Imaging, Ingolstädter Landstr. 1, 85764 Neuherberg, - Tel.: 089-3187-3852 -

Learn more about Helmholtz Enterprise

As German Research Center for Environmental Health, Helmholtz Zentrum München pursues the goal of developing personalized medical approaches for the prevention and therapy of major common diseases such as diabetes mellitus and lung diseases. To achieve this, it investigates the interaction of genetics, environmental factors and lifestyle. The Helmholtz Zentrum München has about 2,300 staff members and is headquartered in Neuherberg in the north of Munich. Helmholtz Zentrum München is a member of the Helmholtz Association, a community of 18 scientific-technical and medical-biological research centers with a total of about 37,000 staff members.

The Helmholtz Association contributes to solving major challenges facing society, science and the economy with top scientific achievements in six research fields: Energy, Earth and Environment, Health, Key Technologies, Structure of Matter, Aeronautics, Space and Transport. With 37.000 employees in 18 research centres and an annual budget of approximately 3.99 billion euros, the Helmholtz Association is Germany’s largest scientific organisation. Its work follows in the tradition of the great natural scientist Hermann von Helmholtz (1821-1894).

We use cookies to improve your experience on our Website. We need cookies to continually improve our services, enable certain features, and when we embed third-party services or content, such as the Vimeo video player or Twitter feeds. In such cases, information may also be transferred to third parties. By using our website, you agree to the use of cookies. We use different types of cookies. You can personalize your cookie settings here:

Show detail settings
Please find more information in our privacy statement.

There you may also change your settings later.